DIN 02498316 — RIXIMYO 10 MG
RIXIMYO is a solution of Rituximab marketed by SANDOZ CANADA INCORPORATED. The full Rituximab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02498316
- Brand name
- RIXIMYO
- Active ingredient
- Rituximab
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Anti-CD20 monoclonal antibody (antineoplastic/immunosuppressive agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Rituximab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02241927 | RITUXAN | 10 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02457350 | RITUXAN SC | 1400 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02473976 | RITUXAN SC | 1600 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02495724 | RUXIENCE | 10 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02478382 | TRUXIMA | 100 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02478390 | TRUXIMA | 500 MG | SOLUTION | CELLTRION INC. | MARKETED |